"breast cancer survivor" trang 9 - tải miễn phí từ tailieuXANH
Initial and ten-year treatment patterns among 11,000 breast cancer patients undergoing breast surgery-an analysis of German claims data

Initial and ten-year treatment patterns among 11,000 breast cancer patients undergoing breast surgery-an analysis of German claims data
12    15    1
Identification of candidate cancer predisposing variants by performing wholeexome sequencing on index patients from BRCA1 and BRCA2-negative breast cancer families

Identification of candidate cancer predisposing variants by performing wholeexome sequencing on index patients from BRCA1 and BRCA2-negative breast cancer families
11    70    0
Breast cancer metastasis suppressor 1 (BRMS1) attenuates TGF-β1-induced breast cancer cell aggressiveness through downregulating HIF-1α expression

Breast cancer metastasis suppressor 1 (BRMS1) attenuates TGF-β1-induced breast cancer cell aggressiveness through downregulating HIF-1α expression
9    53    0
Breast magnetic resonance imaging for surveillance of women with a personal history of breast cancer: Outcomes stratified by interval between definitive surgery and surveillance MR imaging

Breast magnetic resonance imaging for surveillance of women with a personal history of breast cancer: Outcomes stratified by interval between definitive surgery and surveillance MR imaging
8    108    0
Study protocol of the CAREST-trial: A randomised controlled trial on the (cost-) effectiveness of a CBT-based online selfhelp training for fear of cancer recurrence in women with curatively treated breast cancer

Study protocol of the CAREST-trial: A randomised controlled trial on the (cost-) effectiveness of a CBT-based online selfhelp training for fear of cancer recurrence in women with curatively treated breast cancer
11    98    0
Long non-coding RNA BRE-AS1 inhibits the proliferation, migration, and invasion of cancer cells in triple-negative breast cancer and predicts patients’ survival by downregulating miR-21

Long non-coding RNA BRE-AS1 inhibits the proliferation, migration, and invasion of cancer cells in triple-negative breast cancer and predicts patients’ survival by downregulating miR-21
10    268    1
Androgen receptor and FOXA1 coexpression define a “luminal-AR” subtype of feline mammary carcinomas, spontaneous models of breast cancer

Androgen receptor and FOXA1 coexpression define a “luminal-AR” subtype of feline mammary carcinomas, spontaneous models of breast cancer
16    56    0
Health-related quality of life in patients receiving first-line eribulin mesylate with or without trastuzumab for locally recurrent or metastatic breast cancer

Health-related quality of life in patients receiving first-line eribulin mesylate with or without trastuzumab for locally recurrent or metastatic breast cancer
10    59    0
Predictors of mammographic density among women with a strong family history of breast cancer

Predictors of mammographic density among women with a strong family history of breast cancer
12    81    0
Investigating the effects of additional truncating variants in DNA-repair genes on breast cancer risk in BRCA1-positive women

Investigating the effects of additional truncating variants in DNA-repair genes on breast cancer risk in BRCA1-positive women
12    58    0
Systemic high-dose intravenous methotrexate in patients with central nervous system metastatic breast cancer

Systemic high-dose intravenous methotrexate in patients with central nervous system metastatic breast cancer
6    64    0
Successfully treatment by eribulin in visceral crisis: A case of lymphangitic carcinomatosis from metastatic breast cancer

Successfully treatment by eribulin in visceral crisis: A case of lymphangitic carcinomatosis from metastatic breast cancer
5    69    0
Filtration based assessment of CTCs and CellSearch® based assessment are both powerful predictors of prognosis for metastatic breast cancer patients

Filtration based assessment of CTCs and CellSearch® based assessment are both powerful predictors of prognosis for metastatic breast cancer patients
8    96    0
Longitudinal autoantibody responses against tumor-associated antigens decrease in breast cancer patients according to treatment modality

Longitudinal autoantibody responses against tumor-associated antigens decrease in breast cancer patients according to treatment modality
9    80    0
Phase II trial of eribulin mesylate as a firstor second-line treatment for locally advanced or metastatic breast cancer: A multicenter, single-arm trial

Phase II trial of eribulin mesylate as a firstor second-line treatment for locally advanced or metastatic breast cancer: A multicenter, single-arm trial
7    92    0
Differences in elongation of very long chain fatty acids and fatty acid metabolism between triple-negative and hormone receptor-positive breast cancer

Differences in elongation of very long chain fatty acids and fatty acid metabolism between triple-negative and hormone receptor-positive breast cancer
21    142    0
The PREgnancy and FERtility (PREFER) study: An Italian multicenter prospective cohort study on fertility preservation and pregnancy issues in young breast cancer patients

The PREgnancy and FERtility (PREFER) study: An Italian multicenter prospective cohort study on fertility preservation and pregnancy issues in young breast cancer patients
11    114    0
Delphinidin induced protective autophagy via mTOR pathway suppression and AMPK pathway activation in HER-2 positive breast cancer cells

Delphinidin induced protective autophagy via mTOR pathway suppression and AMPK pathway activation in HER-2 positive breast cancer cells
13    69    0
Incidence, pattern and prognosis of brain metastases in patients with metastatic triple negative breast cancer

Incidence, pattern and prognosis of brain metastases in patients with metastatic triple negative breast cancer
8    85    0
Plasma HER2ECD a promising test for patient prognosis and prediction of response in HER2 positive breast cancer: Results of a randomized study - SAKK 22/99

Plasma HER2ECD a promising test for patient prognosis and prediction of response in HER2 positive breast cancer: Results of a randomized study - SAKK 22/99
9    64    0
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.